MRPL13 and breast carcinoma: Cai et al. [53] reported that MRPL13 promoted breast cancer invasion, metastasis, and epithelial–mesenchymal transition (EMT) through the PI3K/AKT/mTOR signaling pathway, highlighting its involvement in cancer progression.